SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-96-003835
Filing Date
1996-03-04
Accepted
1996-03-04 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBVF INC.BVF PARTNERS L.P.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A SC 13D/A 20111
2 EXHIBIT 99.A AGREEMENT REGARDING JOINT FILING EX-99.A 1673
3 EXHIBIT 99.B TRANSACTIONS IN THE STOCK EX-99.B 1933
  Complete submission text file 0000912057-96-003835.txt   26133
Mailing Address 100 BEAVER STREET WALTHAM MA 02154
Business Address 1OO BEAVER ST WALTHAM MA 02154 6178935007
GENOME THERAPEUTICS CORP (Subject) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: SC 13D/A | Act: 34 | File No.: 005-34935 | Film No.: 96531051
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE